We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
-1.36%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.32B
AUM Growth
-$280M
(-18%)
Cap. Flow
-$198M
Cap. Flow
% of AUM
-15.04%
Top 10 Holdings %
Top 10 Hldgs %
17.04%
Holding
1,626
New
448
Increased
346
Reduced
313
Closed
483
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$9.86M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$9.7M |
| 3 |
CNR
Core Natural Resources Inc
CNR
|
+$8.26M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$6.63M |
| 5 |
Oracle
ORCL
|
+$6.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMAR
Smartsheet Inc.
SMAR
|
+$14M |
| 2 |
HTLF
Heartland Financial USA, Inc.
HTLF
|
+$11.1M |
| 3 |
NVIDIA
NVDA
|
+$9.36M |
| 4 |
Amazon
AMZN
|
+$8.75M |
| 5 |
Netflix
NFLX
|
+$8.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.2% |
| 2 | Healthcare | 10.48% |
| 3 | Consumer Discretionary | 9.93% |
| 4 | Financials | 7.26% |
| 5 | Communication Services | 6.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Vail Resorts
MTN
$5.23B
| $1.29M | 0.1% |
8,087
+1,248
| +18% | +$207K |
|
252
Goldman Sachs
GS
$301B
| $1.29M | 0.1% |
2,359
-1,095
| -32% | -$659K |
|
253
Equitable Holdings
EQH
$14.5B
| $1.28M | 0.1% |
24,636
+11,521
| +88% | +$603K |
|
254
CALL
Intercontinental Exchange
ICE
$85.2B
| $1.28M | 0.1% |
7,400
-1,300
| -15% | -$213K |
|
255
Viking Therapeutics
VKTX
$3.99B
| $1.27M | 0.1% |
52,467
-1,299
| -2% | -$41.1K |
|
256
Intel
INTC
$496B
| $1.26M | 0.1% |
55,615
+41,765
| +302% | +$914K |
|
257
Genius Sports
GENI
$2.09B
| $1.26M | 0.1% |
126,162
-35,036
| -22% | -$325K |
|
258
Palo Alto Networks
PANW
$311B
| $1.26M | 0.1% |
7,384
+302
| +4% | +$55.8K |
|
259
Star Bulk Carriers
SBLK
$3.18B
| $1.25M | 0.1% |
+80,545
| New | +$1.26M |
|
260
General Motors
GM
$77.9B
| $1.24M | 0.09% |
26,286
-40,239
| -60% | -$1.98M |
|
261
Take-Two Interactive
TTWO
$47.4B
| $1.23M | 0.09% |
5,914
+1,114
| +23% | +$223K |
|
|
FLIC
262
DELISTED
First of Long Island Corp
FLIC
| $1.22M | 0.09% |
+99,010
| New | +$1.24M |
|
263
Federal Realty Investment Trust
FRT
$10.2B
| $1.22M | 0.09% |
12,473
-2,652
| -18% | -$276K |
|
|
NVO
264
Novo Nordisk
NVO
$209B
| $1.2M | 0.09% |
+17,214
| New | +$1.42M |
|
265
PUT
On Holding
ONON
$12.9B
| $1.19M | 0.09% |
+27,200
| New | +$1.43M |
|
|
HEES
266
DELISTED
H&E Equipment Services
HEES
| $1.19M | 0.09% |
+12,586
| New | +$1.1M |
|
267
Liberty Live Group Series C
LLYVK
$9.55B
| $1.19M | 0.09% |
17,475
+3,693
| +27% | +$263K |
|
268
Interactive Brokers
IBKR
$41B
| $1.18M | 0.09% |
+28,428
| New | +$1.41M |
|
269
Check Point Software Technologies
CHKP
$13.3B
| $1.17M | 0.09% |
5,153
+2,140
| +71% | +$453K |
|
270
PUT
CrowdStrike
CRWD
$230B
| $1.16M | 0.09% |
+13,200
| New | +$1.26M |
|
271
Roblox
RBLX
$27.5B
| $1.16M | 0.09% |
19,912
-270
| -1% | -$17K |
|
272
Alamos Gold
AGI
$13.9B
| $1.16M | 0.09% |
43,387
-39,331
| -48% | -$887K |
|
273
3M
MMM
$93.8B
| $1.15M | 0.09% |
+7,842
| New | +$1.15M |
|
|
CUK
274
DELISTED
Carnival PLC
CUK
| $1.15M | 0.09% |
+65,636
| New | +$1.41M |
|
275
Cytokinetics
CYTK
$10.4B
| $1.15M | 0.09% |
28,554
+8,348
| +41% | +$384K |
|
Similar funds
PFBT
CCP
SP
HCS
SPC
GPCM
MCM
CC
Prelude Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Prelude Capital Management held 1,626 positions worth $1.32B, down 18% from $1.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Prelude Capital Management withdrew a net $198M in Q1 2025, closing 483 positions and reducing 313 holdings. Its most notable exit was Smartsheet Inc., an estimated $14M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Prelude Capital Management opened a new position in Intra-Cellular Therapies Inc. worth $10.4M.
- Prelude Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 79,142 shares worth $10.4M.
- Prelude Capital Management added most to Alphabet (Google) Class A in Q1 2025, an estimated $9.7M increase.
- Prelude Capital Management's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $9.36M.
- Prelude Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $14M.
- Prelude Capital Management's ten largest holdings make up 17% of its $1.32B portfolio in Q1 2025.
- Prelude Capital Management opened 448 new positions and closed 483 in Q1 2025.
- Prelude Capital Management's portfolio value fell 18% quarter-over-quarter to $1.32B.
Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.